Foresight Acquisition Corp. II

Foresight Acquisition Corp. II

Jun 8, 2021 by sam.beattie

MANAGEMENT & BOARD


Executive Officers

Michael Balkin, 62
Chief Executive Officer and Director

Mr. Balkin also serves as Chief Executive Officer and a Director of Foresight I. Mr. Balkin has over 30 years of experience in working with public companies in the small cap space. Mr. Balkin was a partner and formerly the co-Manager of the William Blair Small Institutional portfolio and the William Blair Small Cap Growth Fund, which he and his partners, Karl Brewer and Mark Fuller started, in 1999. He and his team managed nearly $1.8 billion dollars in total assets and have been named among the top small cap funds multiple times by publications such as Barrons, Morningstar, Lipper and Institutional Investor Magazine. From 2005 to 2008, Mr. Balkin was a partner at Magnetar Capital, LLC, a multi-strategy hedge fund located in Evanston, Illinois. While at Magnetar, Mr. Balkin was the Portfolio Manager in charge of the small cap long-short strategy and was also the Chief Investment Officer of Magnetar Investment Management, a wholly owned asset management subsidiary of Magnetar Capital. He rejoined William Blair & Company in 2008. He originally joined William Blair in 1990, working in the sell-side institutional research sales group, specializing in small cap growth companies. Prior to joining William Blair, he was the co-founder of Cityview Associates, Inc., a real estate firm specializing in “value-added” real estate transactions. Prior to starting Cityview Associates, Mr. Balkin had various roles at First Chicago and Bankers Trust. In addition to his work with William Blair, Mr. Balkin has helped dozens of small companies grow as an angel investor, mentor and board member. He is currently the Chairman of the Board of Performance Health Systems, LLC and is a member of the board of managers of the Innventure Fund, an Intellectual Property-based development fund started by Greg Wasson. Mr. Balkin is also active in many charities and is on the board of the Friends of the Israeli Defense Forces, Good Sports and is a major advocate and fund raiser for Cystic Fibrosis and the Illinois Holocaust Museum. Mr. Balkin graduated with a Bachelor’s degree in Economics from Northwestern University, where he was also a two year Captain of the tennis team.


Gerald Muizelaar, 46
Chief Financial Officer

Mr. Muizelaar also serves as Chief Financial Officer of Foresight I. Mr. Muizelaar brings over 15 years of financial leadership in private equity, manufacturing, retail and customer service. Mr. Muizelaar has served as Vice President of Finance for Wasson Enterprise, the family office of Greg Wasson, since 2017. Mr. Muizelaar’s strong focus implementing robust financial processes and systems, ensuring regulatory compliance, and bolstered financial visibility have been a key factor in Wasson Enterprise’s success. As a former North American Finance Manager for Amazon, Mr. Muizelaar led all U.S., Canadian and Latin American customer service finance teams. He and his team provided financial insights and analysis for a customer service network that encompassed over 10,000 employees and an annual P&L in excess of $250 million. Mr. Muizelaar’s leadership and deep understanding of operations were influential in optimizing costs for Amazon’s North American Customer Service team, while simultaneously growing its operations by 30% annually and consistently driving quality improvements to keep Amazon ranked #1 in the World for Customer Service. Mr. Muizelaar holds a Bachelor of Business Administration from Acadia University and a MBA from Dalhousie University.


Board of Directors

Greg Wasson, 62
Chairman

Mr. Wasson currently serves as President and Founder of his own family office, Wasson Enterprise. Wasson Enterprise’s focus is to partner with entrepreneurs and operators to build sustainable, high-growth businesses that do well by doing good. Mr. Wasson also serves Chairman of the Board of Foresight I. As the former CEO of Walgreens, Mr. Wasson has extensive global operational and management experience, as well as extensive knowledge of the retail and healthcare industries. Mr. Wasson attended Purdue University’s School of Pharmacy, receiving his pharmacy degree in 1981. Before his senior year, he was invited to become one of the first pharmacy services interns in Walgreens’ corporate offices—an opportunity that led to his being hired by Walgreens upon graduation and that changed the course of his future career. Mentored by many company leaders through the years, together with his outstanding performance in positions of increasing responsibility, Mr. Wasson served Walgreens for 34 years. As Walgreens CEO, Mr. Wasson led the Fortune 35 company to record fiscal 2014 sales of $76.4 billion. He is credited with creating significant financial and shareholder value, initiating and completing transformative mergers and investments, leading complex organizational and structural change, assembling a diverse and high-performance senior leadership team, and establishing Walgreens’ position as an industry leader. Before retiring from Walgreens, Mr. Wasson had transformed an iconic 114-year-old domestic company into the first global pharmacy-led, health, well-being and beauty enterprise via the successful merger with European-based Alliance Boots to create Walgreens Boots Alliance. Mr. Wasson currently serves on the Board of Directors of OptimizeRx Corp. (NASDAQ: OPRX).


Judith Sprieser, 67
Director Nominee

Judith Sprieser has agreed to serve on the Board of Directors. Ms. Sprieser brings over 35 years of broad financial experience including audit and governance, as well as business management experience. She founded Transora, Inc., a technology software and services company, in 2000 and served as its Chief Executive Officer until 2005. Prior to founding Transora, Ms. Sprieser was Executive Vice President of Sara Lee Corporation, serving as CEO of the Food Group and prior to that as Chief Financial Officer. Ms. Sprieser has been a member of the Boards of Directors of Allstate Insurance Company (NYSE: ALL) since 1999 (most recently as Lead Director), Intercontinental Exchange, Inc. (NYSE: ICE) since 2004, where she chairs the Audit Committee and Newell Brands Inc. (NASDAQ: NWL) since May 2018, where she chairs the Audit Committee. Previously, she served on the Boards of Royal Ahold N.V. from 2006 to 2015, Experian plc from 2010 to 2016 and Reckitt Benckiser plc from 2003 to 2018. Ms. Sprieser is also a Trustee of Northwestern University. Ms. Sprieser earned a Bachelor of Arts degree from Northwestern University and a Master of Business Administration from the Kellogg School of Management at Northwestern University.


Wanji Walcott, 51
Director Nominee

Ms. Walcott serves as the Chief Legal Officer and General Counsel at Discover Financial Services (NYSE: DFS), a financial services company that owns Diners Club International, the Discover and Pulse networks and operates Discover Bank, since July 2019. As a member of Discover’s Executive Committee, Ms. Walcott is responsible for the company’s legal and government relations functions and co-leads the company’s innovation initiative. She has worked across various industries both in corporate legal departments and in private practice, structuring mergers & acquisitions and strategic transactions, as well as advising on innovative product and feature launches, risk management and governance matters. From February 2017 until joining Discover, Ms. Walcott was Senior Vice President, General Counsel and previously Vice President, Legal from 2015 to 2017 at PayPal Holdings, Inc. a global payments provider enabling digital and mobile payments on behalf of consumers and merchants. From 2002 to 2015 she held various positions at American Express, including Senior Vice President, Managing Counsel. Earlier in her career, Ms. Walcott held legal positions at Pillsbury Winthrop Shaw Pittman LLP and Lockheed Martin IMS Corporation. Ms. Walcott earned her undergraduate degree and law degree from Howard University.


Robert Zimmerman, 69
Director Nominee

Mr. Zimmerman has served on the Board of Directors of Foresight I since February 2021. Mr. Zimmerman is an independent consultant since retiring from Walgreens in 2014, focusing on healthcare, specifically retail pharmacy services and pharmacy benefit management. His primary consulting work has been with knowledge transfer companies (GLG and Guidepoint) with significant short-term assignments with end business clients as well as hedge funds and consulting firms. He has also consulted directly with private equity and hedge funds. Until April 2014, Mr. Zimmerman served as Chief Strategy Officer and SVP of Corporate Development at Walgreens. In these roles, he worked directly with the CEO and Executive Committee on strategic plans helping transform Walgreens from a drug store chain to an international integrated health care provider. He also led the development and execution of Walgreens M&A strategy, including the largest transaction in Walgreens’ history, the acquisition of Alliance Boots. Prior to his tenure as CSO, he served as CFO and EVP of WHP Health Initiatives, Walgreens’ managed care division. He held responsibility for the division’s finance, strategy, new business and product development initiatives, acquisitions, pharmaceutical trade relations, and Customer Care Center operations. Mr. Zimmerman currently also serves as a Board Member on the State of Illinois Board of Pharmacy (since 2016), where he was appointed by the Governor of Illinois. Mr. Zimmerman graduated from Eastern Illinois University in 1973 with a Bachelor of Finance, and from Northern Illinois University in 1984 with an MBA.